| Financial Year |
December 31 2020 |
| Monetary Funds |
205,228,088.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
18,161,588.64 |
| Accounts Receivable |
543,868,013.61 |
| Advances to Suppliers |
261,827,870.14 |
| Other Receivables |
66,478,784.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,261,971,501.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
311,924,499.59 |
| Total Current Assets |
4,669,460,347.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
323,240,451.07 |
| Investment Properties |
40,602,332.10 |
| Fixed Assetes |
2,266,785,480.75 |
| Under-construction Projects |
292,482,710.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
5,640,429.05 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
289,523,244.68 |
| R&D expenses |
24,346,536.89 |
| Goodwill |
466,539,005.66 |
| Long-Term Deferred and Prepaid Expenses |
41,343,729.98 |
| Deferred Income Tax Assets |
36,547,195.58 |
| Other Non-Current Assets |
523,670,810.76 |
| Sub-Total of Non-Current Assets |
4,407,598,466.18 |
| Total Assets |
9,077,058,813.52 |
| Short-Term Loans |
1,581,033,333.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
324,447,554.94 |
| Accounts Payable |
502,253,202.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,330,588.36 |
| Taxes Payable |
26,778,559.29 |
| Interest Payable |
41,085,000.00 |
| Dividend Payable |
-- |
| Other payables |
86,423,139.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
979,871,307.58 |
| Other Current Liabilities |
3,587,656.65 |
| Sub-Total of Current Liabilities |
3,564,184,166.65 |
| Long-term Loans |
2,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
19,510,917.61 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,825,000.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
91,838,930.79 |
| Total Liabilities |
3,656,023,097.44 |
| Paid-In Capital(Or Share Stock) |
766,773,200.00 |
| Capital Surplus |
2,934,531,398.48 |
| Surplus Reserve |
102,084,065.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,433,072,694.66 |
| Minority Stockholder's Interest |
183,203,850.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,237,831,865.89 |
| Owner's Equity（Stockholder's Equity） |
5,421,035,716.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,077,058,813.52 |
